of interest. The synthesis of such probes is described later in this series.'4' Southern blotting is a DNA-DNA hybridisation technique that is often used to identify, for example, the location of a single gene on chromosomal DNA (fig 1) .
Before were identified in many patients with ischaemic heart disease. Interestingly, none of these alleles was associated with variations in cholesterol or apolipoprotein B concentrations, suggesting that genetic variation at the locus for apolipoprotein may be an independent, though unknown, risk factor for ischaemic heart disease. 
Problems
The usefulness of these tests relies on gene linkage analysis when the exact site of the abnormal gene is unknown, as often happens. The probes used usually detect nucleic acid sequences close to, rather than within the affected gene. As "swapping" recombination occurs between genes of paired chromosomes, in about 5% of samples the probe marker will no longer be physically associated with the abnormal gene, resulting in a probability of detecting carriage of the gene of only 95%.7X The accuracy of this method obviously varies, depending on how close the nucleic acid sequence that is being identified is to the gene under study: the larger the distance the higher the probability of error. Such a limitation does not apply to probes for genes already known to be responsible for the disease.
A further potential problem of applying these techniques to inherited diseases is that of heterogeneous genes for clinically similar disorders. Thus information relating to a patient's pedigree is essential for accurate analysis of certain diseases, such as autosomal dominant manic depressive disease, in which genetic heterogeneity is known to exist.8 NORTHERN BLOTTING Northern blotting, which uses DNA probes that hybridise with complementary RNA sequences, is an ideal tool to study the products of gene transcription. For example, overexpression of certain proteins in neoplastic cells can be examined to determine whether the increase is due to gene amplification (an increase in the number of genes), is regulated at a transcriptional level due to gene derepression (where one gene gives rise to increased mRNA), or is due to post-transcriptional mechanisms such as reduced cellular excretion.
Gene amplification has been shown to be responsible for acquired drug resistance in tumour cells in small cell carcinoma, where methotrexate resistance is conferred by amplification of the gene for dihydrofolate reductase. Western blotting has also proved invaluable in protein chemistry applied to such areas as enzymology and oncology-for example, to find different isoenzymes and their pattern of distribution in diseased and healthy tissue. Similarly, the identification and localisation of tumour markers within neoplastic material can easily be studied with the appropriate antisera.
Future developments
The application of blotting techniques will undoubtedly increase in the next decade. It is likely that rather than being employed in isolation they will complement other areas of technological advance outlined in this series. An example of this is the polymerase chain reaction, in which special heat resistant DNA polymerase enzymes are used to duplicate very small segments of DNA that would ot-herwise go undetected. Once amplified such DNA segments are identified by Southern blotting. This technique has been used to identify infection with HIV many months before antibodies can be detected in the patient's serum. 34 Blotting techniques, which allow detection of genomic material or proteins fairly simply and cheaply with high specificity, are widely used in medical research. Nevertheless, the results depend on the purity of the materials used and the technical skill of those using them.
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